Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8+
SponsorUniversity of Utah

About this trial

The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use during surgical treatment decision making for neuromuscular scoliosis (NMS). Results from this pilot will inform the design of a future larger effectiveness trial of the decision support tool.

Participants will either receive usual care or receive the decision support tool. Researchers will assess the decision made, decision quality, individual affective, cognitive, and behavioral effects, and feasibility and acceptability of tool use. They will also collect potential barriers and facilitators to implementation and feedback about the tool and study design to maximize likelihood of successful deployment of the tool into clinical practice and inform the design of a future trial. The outcomes measures will be used to inform potential effect size estimates to inform a future trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Parent-child dyads of children with neuromuscular scoliosis who speak English and Spanish.

Child is between ages 8-21 years of age and they are coming into the pediatric orthopaedic surgery clinic for consultation about potential surgery for NMS.

NMS is defined as having neurologic impairment (NI) and scoliosis using relevant ICD-9 or ICD-10 codes from Feudtner, et al. 2014 or Berry, et al. 2012. or a qualifying diagnosis per the Pediatric Spine Study Group definition of NMS.

All pediatric orthopaedic surgeons and neurosurgeons who treat neuromuscular scoliosis at our study sites will be eligible participants.

Disqualifiers

Families whose child with NMS is less than 8 years of age at time of orthopaedic consultation because surgery at a younger age usually indicates an atypical case.

Children with the diagnosis of Becker's muscular dystrophy due to potential disease modifying therapies that may alter curve progression.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Decision support tool

    Behavioral

    Decision support tool developed for patients, parents, and providers of children with neuromuscular scoliosis

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: Usual careNo intervention 0 interventions
Group B: Decision support toolExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Intention for NMS treatment

Parent degree of decision preference (1: no surgery-9: surgery)

Time frame
Immediately after clinic visit

Secondary outcomes

1

Intention for NMS treatment

Parent's desired treatment option: Binary (1- surgery, 0- no surgery)

Time frame
Immediately after clinic visit
2

Intention for not delaying treatment

For parents who select surgery, the intention of treatment timing.

Time frame
Immediately after clinic visit
3

Knowledge questions

Parent's response to five decision-related knowledge questions, scored as total answered correctly

Time frame
Immediately after clinic visit
4

Acceptability of intervention

Measured quantitatively by the validated Acceptability of Intervention Measure for caregivers in the intervention group. The scale consists of 4 items rated on a 5-point Likert scale. A mean score is created with a higher score indicating higher acceptability.

Time frame
Immediately after clinic visit

Other outcomes

1

Barriers and facilitators to implementation

Qualitative analysis of interviews and focus groups from intervention group participants using the CFIR

Time frame
Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).
2

Quality of interpretation

5-item survey questions based on Napoles 2015 and qualitative analysis of recorded clinic visits to assess quality of interpretation. The first item assesses the type and need for interpretation, with participants selecting from 7 categories. If an interpreter was used, participants will then answer 4 additional items about the quality of interpretation for the visit. Each of these subsequent items is rated on a 5-point Likert scale (1-poor to 5-excellent). A mean composite outcome of the completed items is used to calculate overall quality.

Time frame
immediately after clinic visit
3

Usability of intervention

System Usability Scale (SUS): The SUS is a validated 10-item survey measure that evaluates the perceived usability of the intervention. Items are rated on a 5-point Likert scale and scores are calculated by converting responses to a 0-100 scale, with higher scores indicating better usability. Only parent participants assigned to the intervention group will answer this measure.

Time frame
Immediately after clinic visit
4

Mental load of intervention

NASA Task Load Index (NASA-TLX): The NASA-TLX is a validated measure used to assess the perceived mental workload of using the intervention. It consists of 6-items to measure 6 core dimensions: mental demand, physical demand, temporal demand, performance, effort, and frustration. Each dimension is rated on a scale from 0 to 100, and scores are combined to produce an overall workload score. Higher scores indicate greater perceived workload. Only parent participants assigned to the intervention group will answer this measure.

Time frame
Immediately after clinic visit

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Utah

Lead sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator